Skip to main content
2855 search results for:

Ustekinumab 

sort by |
"newest" sorts results by publication date. "most relevant" also considers factors like how often the search phrase is in the result.
  1. 03-05-2024 | Ustekinumab | Online First

    STEP-CD study: ustekinumab use in paediatric Crohn’s disease—a multicentre retrospective study from paediatric IBD Porto group of ESPGHAN

    Ustekinumab is an effective therapy for adult Crohn’s disease (CD), but data in paediatric CD patients are scarce. The aim of the study was to describe the real-life effectiveness and safety of ustekinumab in paediatric CD. This is a multicentre …

  2. Open Access 28-02-2024 | Guselkumab | OriginalPaper

    Comparing Efficacy of Guselkumab versus Ustekinumab in Patients with Psoriatic Arthritis: An Adjusted Comparison Using Individual Patient Data from the DISCOVER and PSUMMIT Trials

    Treatment for psoriatic arthritis (PsA), a chronic inflammatory condition, has evolved from traditional disease-modifying antirheumatic drugs (DMARDs) to targeted synthetic and biologic DMARDs [ 1 , 2 ]. Specifically, biologic therapies that …

  3. 19-12-2023 | Ustekinumab | Report

    Dual-Targeted Therapy with Upadacitinib and Ustekinumab in Medically Complex Crohn’s Disease

    Crohn’s disease (CD) is a chronic inflammatory disease that affects the gastrointestinal tract and has a large impact on quality of life [ 1 ]. CD is often a progressive disease, with approximately half of the CD population having a disease course …

  4. 01-01-2024 | Ustekinumab | News

    Ustekinumab: lupus-related conditions and opportunistic infections

  5. Open Access 01-02-2024 | Guselkumab | OriginalPaper

    Brodalumab Versus Guselkumab in Patients with Moderate-to-Severe Psoriasis with an Inadequate Response to Ustekinumab: A Randomized, Multicenter, Double-Blind Phase 4 Trial (COBRA)

    With increasing availability of novel biologics with new targets for psoriasis, the complexity of choosing the appropriate biologic treatment is ever more challenging for physicians. This applies not only to choosing the most appropriate treatment …

  6. 01-11-2023 | Human Papillomavirus | News

    Ustekinumab

    Human papillomavirus infection: case report
  7. 01-08-2023 | Ustekinumab | News

    Ustekinumab

    Eosinophilic pneumonia: case report
  8. 01-05-2023 | Lung Cancer | News

    Ustekinumab/vedolizumab

    Various toxicities: 4 case reports
  9. 01-04-2023 | Pharyngitis | News

    Ustekinumab

    Various toxicities: 8 case reports
  10. Open Access 22-11-2023 | Ustekinumab | OriginalPaper

    Efficacy and Safety of Candidate Biosimilar CT-P43 Versus Originator Ustekinumab in Moderate to Severe Plaque Psoriasis: 28-Week Results of a Randomised, Active-Controlled, Double-Blind, Phase III Study

    Plaque psoriasis is a chronic, immune-mediated inflammatory disease, with an estimated prevalence of ≥ 1.5% in regions such as Australasia and Western and Central Europe, and in areas of North America [ 1 ]. Ustekinumab is a monoclonal antibody …

  11. Open Access 13-10-2023 | Ustekinumab | OriginalPaper

    Analytical and Functional Similarity of the Biosimilar Candidate ABP 654 to Ustekinumab Reference Product

    ABP 654 is a proposed biosimilar to ustekinumab [ 1 ] reference product (RP), a human immunoglobulin (Ig) isotype class G subclass 1 kappa monoclonal antibody that binds to the common p40 subunit of cytokines interleukin (IL)-23 and IL-12. Binding …

  12. 01-09-2023 | Ustekinumab | News

    Ustekinumab/vedolizumab

    Treatment failure and various toxicities: 7 case reports
  13. 01-09-2022 | Cerebral Sinus Venous Thrombosis | News

    Ustekinumab

    Various toxicities: 7 case reports
  14. 01-08-2023 | Ustekinumab | News

    Ustekinumab

    Hodgkin's lymphoma: case report
  15. 01-08-2022 | Ustekinumab | News

    Ustekinumab

    Treatment failure: case report
  16. 01-08-2022 | Melanoma | News

    Ustekinumab

    Various toxicities: 4 case reports
  17. 01-07-2022 | Sarcoidosis | News

    Ustekinumab

    Acute sarcoid myopathy and neuropathy aggravation: case report
  18. 01-07-2022 | Paracetamol | News

    Ustekinumab

    Hypersensitivity reaction to excipient edetic acid: case report
  19. Open Access 01-12-2022 | Crohn's Disease | OriginalPaper

    Stelara struck: a case of noninfectious pneumonitis secondary to ustekinumab

    One of the most common diagnoses for admission to the intensive care unit (ICU) is acute respiratory distress syndrome (ARDS). ARDS is a syndrome characterized by sudden onset of hypoxic respiratory failure, with bilateral infiltrates found on …

  20. 01-05-2022 | Infliximab | News

    Ustekinumab

    Ewing's sarcoma following off-label use: case report

Filter search results

Search Operators:

„ ... ... “ Finds documents with exactly this word group, in exactly this word order and spelling (e.g., "employer branding").
AND Finds documents with both search terms (e.g., sales AND bonus).
OR Finds documents with one or the other search term (e.g., porsche OR volkswagen).
Blank Space Finds documents with all search terms. Blank space is understood as AND (e.g., man robot production).
NOT Finds documents with no appearance of the word behind NOT (e.g., ford NOT "harrison ford").
COUNT(...)>n Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g., COUNT(gear)>8).
NEAR(..., ..., ) Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g., NEAR(recruit, professionals, 20)).
* Finds documents with the search term in word versions or composites. The star * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g., lightweight*, *lightweight, *lightweight*).
? Finds documents with the search termn in different spellings."?" allows only one character (e.g., organi?ation).
& + - Special characters are understood as AND (e.g., Miller Bros. & Sons).

You can use operators in your search query to narrow down your results even more.

Tap the operator, or hover the mouse pointer over it, to read more about how it works.